Cargando…
Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
Disease-mediated alterations to drug disposition constitute a significant source of adverse drug reactions. Cisplatin (CDDP) elicits nephrotoxicity due to exposure in proximal tubule cells during renal secretion. Alterations to renal drug transporter expression have been discovered during nonalcohol...
Autores principales: | Jilek, Joseph L., Frost, Kayla L., Jacobus, Kevyn A., He, Wenxi, Toth, Erica L., Goedken, Michael, Cherrington, Nathan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727892/ https://www.ncbi.nlm.nih.gov/pubmed/35024313 http://dx.doi.org/10.1016/j.apsb.2021.05.030 |
Ejemplares similares
-
Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
por: Clarke, John D., et al.
Publicado: (2015) -
Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients
por: Marie, Solène, et al.
Publicado: (2023) -
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
por: Luther, Jay, et al.
Publicado: (2015) -
Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats
por: Arman, Tarana, et al.
Publicado: (2019) -
Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat
por: Kyriakides, Michael, et al.
Publicado: (2014)